NCT00174967 - Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout | Biotech Hunter

Enrollment

153

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

July 31, 2001

Study Completion Date

July 31, 2001

Conditions

Gout

Interventions

DRUG

Placebo

Febuxostat placebo-matching tablets, orally, once daily for up to 4 weeks.

DRUG

Febuxostat

Febuxostat 40 mg, tablets, orally, once daily for up to 4 weeks.

DRUG

Febuxostat

Febuxostat 80 mg, tablets, orally, once daily for up to 4 weeks.

DRUG

Febuxostat

Febuxostat 120 mg, tablets, orally, once daily for up to 4 weeks.